Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016
May 02 2016 - 8:30AM
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields
of cancer metabolism and rare genetic metabolic disorders, today
announced that the company will host a conference call and live
webcast on Thursday, May 5, 2016 at 8:30 a.m. ET to report its
first quarter 2016 financial results and discuss recent clinical
development and corporate activities.
The live webcast can be accessed under "Events &
Presentations" in the Investors and Media section of the company's
website at www.agios.com. The conference call can be accessed by
dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international)
and referring to conference ID 4063167. The webcast will be
archived and made available for replay on the company's website
beginning approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat cancer and rare
genetic metabolic disorders through scientific leadership in the
field of cellular metabolism. In addition to an active research and
discovery pipeline across both therapeutic areas, Agios has
multiple first-in-class investigational medicines in clinical
and/or preclinical development. All Agios programs focus on
genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more
information, please visit the company's website at
www.agios.com.
Contact:
Renee Leck, Senior Manager, Investor & Public Relations
Renee.Leck@agios.com
617-649-8299
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024